FDA Proposes Exemptions for Clinical Investigations of Lawfully Marketed Foods and Cosmetics

Summary

The US Food and Drug Administration (FDA) is proposing to exempt certain clinical investigations of lawfully marketed foods and cosmetics from the requirements of an Investigational New Drug (IND) application, allowing for the study of these products to evaluate their use as a drug, under specific conditions.